Access to your prescribing team throughout treatment for dose reviews, side effect management, and clinical queries
This does not mean your weight loss was a mistake
Protocol 2: significant weight loss (20-25% body weight) Goal: Substantial weight reduction for health improvement Tirzepatide approach: Full escalation to 10-15 mg Expect to reach target dose by week 17-21 Weight loss at 15 mg: approximately 22.5% at 72 weeks Plateau typically occurs around weeks 60-72 Retatrutide approach: Full escalation to 8-12 mg Expect to reach target dose by week 13-17 Weight loss at 12 mg: 24.2% at 48 weeks, 28.7% at 68 weeks No plateau observed in trial data at 48 or 68 weeks For significant weight loss goals, retatrutide reaches 20%+ body weight reduction faster and ultimately achieves a higher ceiling
We combine medication with nutritional guidance, physical activity, and behavioral support to maximize and sustain results
In particular, officials have called out versions that may contain ingredients that are similar to the active ingredient semaglutide but chemically different because they are in salt form
Retatrutide has received attention for strong clinical trial results, but it is not currently FDA-approved